|
US2086186A
(en)
|
1933-10-10 |
1937-07-06 |
Us Rubber Co |
Treatment of rubber
|
|
GB1435721A
(en)
|
1972-05-18 |
1976-05-12 |
Lilly Industries Ltd |
Benzoxazole derivatives
|
|
SU509046A1
(ru)
|
1975-02-21 |
1984-06-23 |
Всесоюзный научно-исследовательский химико-фармацевтический институт им.Серго Орджоникидзе |
Производные 2-карбэтокси-3-аминоиндола,про вл ющие противовоспалительную активность, и способ их получени
|
|
US4675332A
(en)
|
1984-12-10 |
1987-06-23 |
Warner-Lambert Company |
Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
|
|
GB8610981D0
(en)
|
1986-05-06 |
1986-06-11 |
Ici America Inc |
Quinoline amides
|
|
NZ225045A
(en)
|
1987-07-01 |
1990-06-26 |
Janssen Pharmaceutica Nv |
Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent
|
|
US5002935A
(en)
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
|
US5376645A
(en)
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
|
AU8942491A
(en)
|
1990-10-22 |
1992-05-20 |
Bausch & Lomb Incorporated |
Method and composition for cleaning contact lenses
|
|
CA2054339C
(en)
|
1990-11-02 |
2002-12-24 |
Francesco G. Salituro |
3-amidoindolyl derivatives
|
|
US5668117A
(en)
|
1991-02-22 |
1997-09-16 |
Shapiro; Howard K. |
Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
|
|
US20050090553A1
(en)
|
1992-06-30 |
2005-04-28 |
Shapiro Howard K. |
Compositions and method for treatment of chronic inflammatory diseases
|
|
US6444221B1
(en)
|
1992-06-30 |
2002-09-03 |
Howard K. Shapiro |
Methods of treating chronic inflammatory diseases using carbonyl trapping agents
|
|
US5472954A
(en)
|
1992-07-14 |
1995-12-05 |
Cyclops H.F. |
Cyclodextrin complexation
|
|
TW401300B
(en)
|
1992-12-25 |
2000-08-11 |
Senju Pharma Co |
Antiallergic composition for ophthalmic or nasal use
|
|
US5493027A
(en)
|
1993-01-22 |
1996-02-20 |
Board Of Regents, The University Of Texas System |
Anticonvulsive agents and uses thereof
|
|
US5767109A
(en)
|
1993-10-20 |
1998-06-16 |
Sanchez; Robert A. |
Complexing urushiols
|
|
US5576311A
(en)
|
1994-11-30 |
1996-11-19 |
Pharmos Corporation |
Cyclodextrins as suspending agents for pharmaceutical suspensions
|
|
JP3297969B2
(ja)
|
1994-12-26 |
2002-07-02 |
ライオン株式会社 |
点眼剤
|
|
US5597823A
(en)
|
1995-01-27 |
1997-01-28 |
Abbott Laboratories |
Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
|
|
JP3736916B2
(ja)
|
1996-02-19 |
2006-01-18 |
株式会社サンコンタクトレンズ |
含水性ソフトコンタクトレンズの消毒用組成物とその用途
|
|
KR20000029694A
(ko)
|
1996-08-01 |
2000-05-25 |
케네쓰 엘. 로에르트셔 |
살진균활성을갖는4-치환된퀴놀린유도체
|
|
WO1998050372A1
(de)
|
1997-05-02 |
1998-11-12 |
Schering Aktiengesellschaft |
Substituierte heterocyclen und deren verwendung in arzneimitteln
|
|
GB2327672A
(en)
|
1997-07-23 |
1999-02-03 |
Merck & Co Inc |
4-(1,2,3,4-Tetrahydro-1,8-naphthyridin-7-yl)butanoyl-glycyl-3(S)-quinolin-3-yl-beta-alanine
|
|
WO1999046237A1
(en)
|
1998-03-12 |
1999-09-16 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases
|
|
US6498154B1
(en)
|
1999-05-04 |
2002-12-24 |
Wyeth |
Cyclic regimens using quinazolinone and benzoxazine derivatives
|
|
US6358948B1
(en)
|
1999-05-04 |
2002-03-19 |
American Home Products Corporation |
Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
|
|
EP1233768A1
(en)
*
|
1999-11-15 |
2002-08-28 |
Smithkline Beecham |
Carvedilol methanesulfonate
|
|
AU1735001A
(en)
|
1999-12-10 |
2001-06-18 |
Senju Pharmaceutical Co., Ltd. |
Cyclodextrin-containing pharmaceutical composition
|
|
US6569879B2
(en)
|
2000-02-18 |
2003-05-27 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
|
JP4748289B2
(ja)
|
2000-06-23 |
2011-08-17 |
ライオン株式会社 |
点眼剤、眼科用組成物及び吸着抑制方法
|
|
FR2827599A1
(fr)
|
2001-07-20 |
2003-01-24 |
Neuro3D |
Composes derives de quinoleine et quinoxaline,preparation et utilisations
|
|
UA83620C2
(ru)
|
2001-12-05 |
2008-08-11 |
Уайт |
Замещенные бензоксазолы и их аналоги как эстрогенные агенты
|
|
US20060014786A1
(en)
|
2002-05-17 |
2006-01-19 |
Rajeev Raut |
Opthalmic pharmaceutical compositions and methods for treating ocular inflammation
|
|
CA2451267A1
(en)
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
WO2004069157A2
(en)
|
2003-01-17 |
2004-08-19 |
Ophthalmic Research Associates, Inc. |
Combinational use of long-acting and short-acting anti-histamines for ocular allergies
|
|
US20040242704A1
(en)
|
2003-03-14 |
2004-12-02 |
University Of Washington, Techtransfer - Invention Licensing |
Stabilized mutant opsin proteins
|
|
EP2301549A1
(en)
|
2003-04-18 |
2011-03-30 |
Advanced Medicine Research Institute |
Remedies for diseases to be applied to eye
|
|
US20060111318A1
(en)
|
2003-04-18 |
2006-05-25 |
Advanced Medicine Research Institute |
Agent for treating eye diseases
|
|
US7297709B2
(en)
|
2003-05-22 |
2007-11-20 |
Abbott Laboratories |
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
|
|
US20040235892A1
(en)
|
2003-05-22 |
2004-11-25 |
Yujia Dai |
Indazole and benzisoxazole kinase inhibitors
|
|
US7083803B2
(en)
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
EP2468729B1
(en)
|
2003-10-15 |
2013-12-25 |
Ube Industries, Ltd. |
Novel indazole derivative
|
|
CA2543644A1
(en)
|
2003-10-27 |
2005-05-06 |
Astellas Pharma Inc. |
Pyrazine derivatives and pharmaceutical use thereof
|
|
KR20060109947A
(ko)
|
2003-11-20 |
2006-10-23 |
오쎄라 파마슈티걸즈, 인크. |
황반 변성 및 다른 안과 질환의 개선
|
|
US20050197292A1
(en)
|
2004-01-30 |
2005-09-08 |
Glennda Smithson |
Compositions and methods for treating T-cell mediated pathological conditions
|
|
EP1722766A2
(en)
|
2004-02-17 |
2006-11-22 |
President And Fellows Of Harvard College |
Management of ophthalmologic disorders, including macular degeneration
|
|
US20050234018A1
(en)
|
2004-04-15 |
2005-10-20 |
Allergan, Inc. |
Drug delivery to the back of the eye
|
|
WO2006002473A1
(en)
|
2004-07-02 |
2006-01-12 |
Adelaide Research & Innovation Pty Ltd |
Method of controlling damage mediated by alpha, beta-unsaturated aldehydes
|
|
CN101048384A
(zh)
|
2004-10-28 |
2007-10-03 |
默克公司 |
促代谢型谷氨酸盐受体的嘧啶和喹啉增效剂
|
|
WO2006077821A1
(ja)
|
2005-01-19 |
2006-07-27 |
Dainippon Sumitomo Pharma Co., Ltd. |
アルドステロン受容体調節剤としての芳香族スルホン化合物
|
|
TW200640443A
(en)
|
2005-02-23 |
2006-12-01 |
Alcon Inc |
Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors
|
|
PT1888548E
(pt)
|
2005-05-26 |
2012-10-30 |
Neuron Systems Inc |
Derivado de quinolina para o tratamento de doenças da retina
|
|
JP4466875B2
(ja)
|
2006-04-05 |
2010-05-26 |
ライオン株式会社 |
ソフトコンタクトレンズ用点眼剤
|
|
KR20080109096A
(ko)
|
2006-04-14 |
2008-12-16 |
프라나 바이오테크놀로지 리미티드 |
연령 관련 황반 변성（에이엠디）의 치료 방법
|
|
JP5194218B2
(ja)
|
2006-06-05 |
2013-05-08 |
株式会社メニコンネクト |
含水性コンタクトレンズの保存方法ならびに該保存方法により保存された含水性コンタクトレンズ
|
|
RU2009106461A
(ru)
|
2006-07-25 |
2010-08-27 |
Энвиво Фармасьютикалз, Инк. (Us) |
Хинолиновые производные
|
|
US8158609B1
(en)
|
2006-11-02 |
2012-04-17 |
Novartis Ag |
Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen
|
|
TW200914437A
(en)
|
2007-06-20 |
2009-04-01 |
Ironwood Pharmaceuticals Inc |
FAAH inhibitors
|
|
MX2010003667A
(es)
|
2007-10-05 |
2010-09-28 |
Acucela Inc |
Compuestos alcoxi para el tratamiento de enfermedades.
|
|
JP6022746B2
(ja)
|
2008-02-11 |
2016-11-09 |
ユニヴァーシティ オブ ワシントン |
加齢関連性網膜機能不全の治療及び予防方法
|
|
CN102177157A
(zh)
|
2008-08-12 |
2011-09-07 |
西特里斯药业公司 |
作为沉默调节蛋白调节剂的苯并*唑类、苯并噻唑类和相关的类似物
|
|
AU2010226249A1
(en)
|
2009-03-17 |
2011-10-13 |
Aciex Therapeutics, Inc. |
Ophthalmic formulations of ketotifen and methods of use
|
|
WO2010133672A1
(en)
|
2009-05-20 |
2010-11-25 |
Clanotech Ab |
Derivatives of quinoline-3-carboxylic acid and their medical use
|
|
US20100331315A1
(en)
|
2009-06-18 |
2010-12-30 |
Mustapha Haddach |
Rhodanines and related heterocycles as kinase inhibitors
|
|
EP2477594A4
(en)
|
2009-07-15 |
2013-03-13 |
Univ Vanderbilt |
ISOKETAL CATCHER AND TREATMENT OF DISEASES WITH OXIDATIVE INJURY
|
|
EP2509596B1
(en)
|
2009-12-08 |
2019-08-28 |
Case Western Reserve University |
Gamma aminoacids for treating ocular disorders
|
|
WO2011072141A1
(en)
|
2009-12-11 |
2011-06-16 |
Neuron Systems, Inc. |
Compositions and methods for the treatment of macular degeneration
|
|
WO2011078204A1
(ja)
|
2009-12-24 |
2011-06-30 |
浜理薬品工業株式会社 |
高脂血症の予防または治療剤、および抗疲労剤
|
|
WO2011116066A1
(en)
|
2010-03-17 |
2011-09-22 |
Concert Pharmaceuticals, Inc. |
Derivatives of dimethylcurcumin
|
|
DK2663550T3
(en)
|
2011-01-12 |
2017-03-27 |
Ventirx Pharmaceuticals Inc |
SUBSTITUTED BENZOAZEPINS AS MODULATORS OF TOLL-LIKE RECEPTORS
|
|
US10463687B2
(en)
|
2011-01-20 |
2019-11-05 |
Cornell University |
Treatments for retinal disorders
|
|
CN103442735B
(zh)
|
2011-01-31 |
2016-11-09 |
特米拉公司 |
用于减轻技术领域中所不希望的医学状况的有效要素
|
|
TWI544922B
(zh)
|
2011-05-19 |
2016-08-11 |
愛爾康研究有限公司 |
高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
|
|
WO2015187942A1
(en)
|
2014-06-04 |
2015-12-10 |
Case Western Reserve University |
Compositions and methods of treating diabetic retinopathy
|
|
US20130190500A1
(en)
*
|
2011-12-12 |
2013-07-25 |
Neuron Systems, Inc. |
Process to prepare 6-chloro-3-amino-2-(2-hydroxypropyl)-1-azanaphthalene
|
|
US20130165419A1
(en)
|
2011-12-21 |
2013-06-27 |
Insite Vision Incorporated |
Combination anti-inflammatory ophthalmic compositions
|
|
IN2015DN00538A
(https=)
|
2012-08-01 |
2015-06-26 |
Lewis And Clark Pharmaceuticals Inc |
|
|
EP2916827B1
(en)
|
2012-11-08 |
2020-06-10 |
Clearside Biomedical Inc. |
Methods for the treatment of ocular disease in human subjects
|
|
RU2015120478A
(ru)
|
2012-12-20 |
2017-01-25 |
Альдейра Терапьютикс, Инк. |
Пери-карбинолы
|
|
CA2898631C
(en)
*
|
2013-01-23 |
2023-06-13 |
Aldeyra Therapeutics, Inc. |
Toxic aldehyde related diseases and treatment
|
|
SG11201505599YA
(en)
|
2013-01-25 |
2015-08-28 |
Aldeyra Therapeutics Inc |
Novel traps in the treatment of macular degeneration
|
|
US9713330B1
(en)
|
2013-03-15 |
2017-07-25 |
Deuteria Agrochemicals, Llc |
Deuterium-enriched aldehydes
|
|
NO2721710T3
(https=)
|
2014-08-21 |
2018-03-31 |
|
|
|
EP3628640B1
(en)
|
2014-09-02 |
2023-08-09 |
Hub Therapeutics |
Methods of making a deuterated or a non-deuterated molecule and pharmaceutical formulations for treatment
|
|
WO2016085939A2
(en)
|
2014-11-24 |
2016-06-02 |
Case Western Reserve University |
Compounds and methods of treating ocular disorders
|
|
CN118724806A
(zh)
|
2015-08-21 |
2024-10-01 |
奥尔德拉医疗公司 |
氘化化合物和其用途
|
|
KR20180073553A
(ko)
|
2015-08-21 |
2018-07-02 |
알데이라 테라퓨틱스, 아이엔씨. |
알데히드 접합체 및 이의 용도
|
|
CA3016759A1
(en)
|
2016-02-28 |
2017-08-31 |
Aldeyra Therapeutics, Inc. |
Treatment of allergic eye conditions with cyclodextrins
|
|
US11129823B2
(en)
|
2016-05-09 |
2021-09-28 |
Aldeyra Therapeutics, Inc. |
Combination treatment of ocular inflammatory disorders and diseases
|
|
AU2017317529A1
(en)
|
2016-08-22 |
2019-02-21 |
Aldeyra Therapeutics, Inc. |
Aldehyde trapping compounds and methods of use thereof
|
|
JP2019532029A
(ja)
|
2016-08-22 |
2019-11-07 |
アルデイラ セラピューティクス， インコーポレイテッド |
アルデヒド補足化合物およびその使用
|
|
MX2019010576A
(es)
|
2017-03-16 |
2019-10-07 |
Aldeyra Therapeutics Inc |
Compuestos polimorficos y usos de los mismos.
|